SBT-8230

N/A

Report date: 2026/04/28 20:00:22

Base Information

Drug NameSBT-8230
Drug Alias NameSBT-8230Asgr1-Tlr8Asgr1-Tlr8-S
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate
Mechanisms of ActionToll like receptor 8 agonistsAnti-ASGR1
TargetsToll like receptor 8Asialoglycoprotein receptor 1
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSilverback Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSilverback Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A